Fei Yao

机构：Shanghai University, Central South University, Anhui University, The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine, Xiangya Hospital Central South University · ORCID：0000-0002-1769-9140

发表论文 94 篇 · 总被引 4379 次 · h-index 28

代表论文

• Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients (2025 · Cell · 被引 94)
• A systematic benchmark of Nanopore long-read RNA sequencing for transcript-level analysis in human cell lines (2025 · Nature Methods · 被引 84)
• Injectable hydrogel harnessing foreskin mesenchymal stem cell-derived extracellular vesicles for treatment of chronic diabetic skin wounds (2024 · Journal of Controlled Release · 被引 20)
• Hyperoside alleviates photoreceptor degeneration by preventing cell senescence through AMPK‐ULK1 signaling (2023 · The FASEB Journal · 被引 11)
• A Complete Telomere-to-Telomere Diploid Reference Genome for Indian Population (2025 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 7)
• An anti-GD2 aptamer-based bifunctional spherical nucleic acid nanoplatform for synergistic therapy targeting MDM2 for retinoblastoma (2024 · Biomedicine & Pharmacotherapy · 被引 7)